Effects of the Triple Monoamine Uptake Inhibitor DOV 102,677 on Alcohol-Motivated Responding and Antidepressant Activity in Alcohol-Preferring (P) Rats

Alcoholism: Clinical and Experimental Research

Volumn 36, Issue 5, 2012, Pages 863-873

  Yang, Andrew R S T ^a   Yi, Heon S ^a   Warnock, Kaitlin T ^a   Mamczarz, Jacek ^b   June, Harry L ^a   Mallick, Nikhil ^b   Krieter, Philip A ^c   Tonelli, Leonardo ^b   Skolnick, Phil ^c   Basile, Anthony S ^c  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c DOV Pharmaceutical Inc   (United States)

Author keywords

Alcohol Responding; Depression; Forced Swim Test; Monoamine Reuptake Inhibitor; P Rats

Indexed keywords

AMITIFADINE; IMIPRAMINE; SUCROSE;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; FOOD INTAKE; FORCED SWIMMING TEST; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; TIME TO MAXIMUM PLASMA CONCENTRATION;

ALCOHOLISM; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DEPRESSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ETHANOL; MALE; NEUROTRANSMITTER UPTAKE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; SUCROSE; SWEETENING AGENTS; SWIMMING;

RATTUS;

EID: 84860448096     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2011.01671.x     Document Type: Article

References (28)

1. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (DSM-IV). American Psychiatric Publishing, Virginia.
2. Cloninger CR (1987) Neurogenetic adaptive mechanisms in alcoholism. Science 236:410-416.
3. Cornelius JR, Salloum IM, Ehler JG, Jarrett PJ, Cornelius MD, Perel JM, Thase ME, Black A (1997) Fluoxetine in depressed alcoholics: a double-blind, placebo-controlled trial. Arch Gen Psychiatry 54:700-705.
4. Cryan JF, Valentino RJ, Lucki I (2005) Assessing substrates underlying the behavioral effects of antidepressants using the modified forced swim test. Neurosci Biobehav Rev 29:547-569.
5. Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 121:66-72.
6. Godfrey CD, Froehlich JC, Stewart RB, Li TK, Murphy JM (1997) Comparison of rats selectively bred for high and low ethanol intake in a forced-swim-test model of depression: effects of desipramine. Physiol Behav 62:729-733.
7. Gonzales RA, Job MO, Doyon WM (2004) The role of mesolimbic dopamine in the development and maintenance of ethanol reinforcement. Pharmacol Ther 103:121-146.
8. Johnson BA (2008) Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Biochem Pharmacol 75:34-56.
9. June HL (2002) Preclinical models to evaluate potential pharmacotherapeutic agents in treating alcoholism and studying the neuropharmacological bases of ethanol-seeking behaviors in rats, in Current Protocols in Neuroscience (Crawley J, Gerfen C, McKay R, Rogawski M, Sibley D, Skolnick P eds), pp 1-23. John Wiley & Sons, New Jersey.
10. June HL, Eiler WLA (2007) Dopaminergic and GABAergic regulation of alcohol-motivated behaviors: novel neuroanatomical substrates, in Handbook of Contemporary Neuropharmacology (Sibley DR, Hanin I, Kuhar M, Skolnick P eds), pp 1-72. John Wiley & Sons, New Jersey.
11. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC (1997) Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 54:313-321.
12. Kranzler HR, Mueller T, Cornelius J, Pettinati HM, Moak D, Martin PR, Anthenelli R, Brower KJ, O'Malley S, Mason BJ, Hasin D, Keller M (2006) Sertraline treatment of co-occurring alcohol dependence and major depression. J Clin Psychopharmacol 26:13-20.
13. Lê AD, Harding S, Juzytsch W, Funk D, Shaham Y (2005) Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats. Psychopharmacology 179:366-373.
14. Le Fauve CE, Litten RZ, Randall CL, Moak DH, Salloum IM, Green AI (2004) Pharmacological treatment of alcohol abuse/dependence with psychiatric comorbidity. Alcohol Clin Exp Res 28:302-312.
15. McBride WJ, Li TK (1998) Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents. Crit Rev Neurobiol 12:339-369.
16. McMillen BA, Shank JE, Williams HL, Basile AS (2007) The effect of DOV 102, 677 on the volitional consumption of ethanol by the Myer's high ethanol preferring rats. Alcohol Clin Exp Res 31:1866-1871.
17. Murphy JM, Stewart RB, Bell RL, Badia-Elder NE, Carr LG, McBride WJ, Lumeng L, Li TK (2002) Phenotypic and genotypic characterization of the Indiana University rat lines selectively bred for high and low alcohol preference. Behav Genet 32:363-388.
18. Myers RD, Robinson DE, West MW, Biggs TA, McMillen BA (1998) Genetics of alcoholism: rapid development of a new high-ethanol-preferring (HEP) strain of female and male rats. Alcohol 16:343-357.
19. Myrick H, Anton R (2004) Recent advances in the pharmacotherapy of alcoholism. Curr Psychiatry Rep 6:332-338.
20. O'Brien SE, Legastelois R, Houchi H, Vilpoux C, Alaux-Cantin S, Pierrefiche O, André E, Naassila M (2011) Fluoxetine, desipramine, and the dual antidepressant milnacipran reduce alcohol self-administration and/or relapse in dependent rats. Neuropsychopharmacology 36:1518-1530.
21. Pettinati HM (2004) Antidepressant treatment of co-occurring depression and alcohol dependence. Biol Psychiatry 56:785-792.
22. Pettinati HM, Rabinowitz AR (2006) Choosing the right medication for the treatment of alcoholism. Curr Psychiatry Rep 8:383-388.
23. Popik P, Krawczyk M, Golembiowska K, Nowak G, Janowsky A, Skolnick P, Lippa AS, Basile AS (2006) Pharmacological profile of the "triple" monoamine neurotransmitter uptake inhibitor, DOV 102, 677. Cell Mol Neurobiol 26:857-873.
24. Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327-336.
25. Rasmussen DD, Alexander LL, Raskind MA, Froehlich JC (2009) The alpha1-adrenergic receptor antagonist, prazosin, reduces alcohol drinking in alcohol-preferring (P) rats. Alcohol Clin Exp Res 33:264-272.
26. Skolnick P, Basile AS (2007) Triple reuptake inhibitors. ("broad spectrum" antidepressants). CNS Neurol Disord Drug Targets 6:141-149.
27. Viglinskaya IV, Overstreet DH, Kashevskaya OP, Badishtov BA, Kampov-Polevoy AB, Seredenin SB, Halikas JA (1995) To drink or not to drink: tests of anxiety and immobility in alcohol-preferring and alcohol-nonpreferring rat strains. Physiol Behav 57:937-941.
28. Willner P (2000) Dopaminergic mechanisms in depression and mania, in Psychopharmacology: The Fourth Generation of Progress (Watson S ed). [Online Edition]. Lippincott Williams & Wilkins, New York. Available at: Accessed September 15, 2011.